Sign in
4

Changes in Ownership

VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-25-000120

EVP, Chief Scientific Officer sold 1,272 shares at $480.00 ($610,560)

  • EVP, Chief Scientific Officer gave up 5,954 shares (to pay taxes)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ALTSHULER DAVID · EVP, Chief Scientific Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-02-26 Shares withheld for taxes : show line 1 in the form 10b5-1 −5,954 $479.61 $2,855,598 34,246 D
2025-02-27 Sale : show line 2 in the form 10b5-1 −1,272 $480.00 $610,560 32,974 D
Open-market sales · 1,272 sh · avg $480.00 · $610,560
Loading xslF345X05/wk-form4_1740777806.xml…